ABSTRACT OBJECTIVES This study investigated clinical characteristics and prognosis of Brugada syndrome (BrS) in patients older than 60 years of age during a long-term follow-up period.
Patients were divided into 2 groups according to their age at the time of diagnosis: the younger group (<60 years of age) and the senior group ($60 years of age).
Clinical histories and 12-lead ECG findings, including those from leads V 1 to V 3 placed at the 2nd, 3rd, or 4th intercostal space were accessed in all patients.
Organic heart diseases were excluded by examinations using ultrasound cardiography, coronary Kitamura et al. 
RESULTS

CLINICAL AND ELECTROPHYSIOLOGICAL CHARACTERISTICS
OF THE 2 GROUPS. The senior group, $60 years of age, consisted of 58 cases (32%), and the younger group, <60, was 123 cases (68%). Mean ages were 68.6 AE 7.1 years in the former and 42.7 AE 11 years in the latter group. The age distribution at diagnosis in all patients is shown in Figure 1 Values are mean AE SD or n (%).
who had a family history of BrS, but all patients in the senior group were probands without family history.
No differences were noted between the 2 groups with Table 2 . Table 4 . In addition, we evaluated alteration, especially attenuation with age, in several parameters during follow-up. There were no changes in r-J interval >90 and fragmented QRS during follow-up.
On the other hand, 2 of 42 patients had day-to-day variations in ER pattern (ER was not documented regularly). Six of 125 patients had a change from Figure 4A shows the number of ICD indication category modified to the latest guideline among all patients and those with implanted ICD. Different outcomes by EPS might be attributed to differences in stimulation protocol, but a prospective study by a fixed stimulation protocol could not demonstrate a predictive value of VT/VF induction for cardiac events (20) .
In the present study, spontaneous type 1 ECG and day-to-day variations in Brugada ECG patterns were significantly less prevalent in the senior group than in the younger group. Type 1 ECG and day-to day variations of Brugada ECG pattern are thought to be risks factor for fatal ventricular arrhythmia depending on different ethnic groups and population of the study subjects, values, and timing of ECG Moreover, attenuation or disappearance of several risk factors with age during follow-up were observed in a small number of patients. Therefore, the true reason why the senior patients showed a better prognosis than the younger group <60 years of age was not clarified by the present study, and further exploration should be continued. In addition, in our Abbreviations as in Tables 1 and 2. case series, there were no VF events after 5-year follow-up, contrary to our expectations. We anticipated that there would be events in the late period of follow-up, as reported in other studies (18, 20) .
Therefore, we also expected that there would be patients with VF events during later follow-up period in future. One possible reason could be that the patients had more time to receive education at outpatient clinics to avoid being exposed to circumstances such as high-grade fever, taking medication worsening BrS ECG (Na channel blockers, calcium channel blockers, and so forth) (33, 34) 
ICD INDICATION FOR THE SENIOR PATIENTS WITH
BRUGADA SYNDROME. In the present study, all patients were reclassified by ICD indication according to the latest consensus statement (9) . Figure 4 shows the distribution of reclassified patients. Patients with ICD insertion were reclassified into class The numbers of the study subjects were rather small.
In addition, a direct correlation between cardiac events during follow-up and the positive findings (i.e., type 1 ECG, day-to-day variation, or prolonged R-J interval) was not confirmed. Furthermore, there were only 11 events during the follow-up period in the present study, which contributed to several risk factors with large hazard ratios and large confidence intervals in Cox regression analysis. Therefore, we might have overestimated the impact of those risk factors, and the results in 
PERSPECTIVES COMPETENCY IN MEDICAL KNOWLEDGE:
Senior BrS patients $60 years of age at diagnosis have a better prognosis than the younger age group.
ICD implantations for BrS patients $60 years of age should be carefully evaluated.
TRANSLATIONAL OUTLOOK: A study with a larger population and a longer follow-up period, specifically a span lasting until the end of life in senior patients, is needed.
